ALKEM vs BIOFILCHEM: Stock Comparison
Alkem Laboratories Limited vs Biofil Chemicals & Pharmaceuticals Limited
Live data: 22 July 2026, 3:07 PM IST • Source: NSE and company filings
Alkem Laboratories Limited is the larger company by market capitalisation. Alkem Laboratories Limited shows a higher ROE, a higher dividend yield and faster revenue growth, while Biofil Chemicals & Pharmaceuticals Limited shows lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Side-by-side comparison of Alkem Laboratories Limited and Biofil Chemicals & Pharmaceuticals Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ALKEM | BIOFILCHEM |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharmaceuticals |
Price
| Metric | ALKEM | BIOFILCHEM |
|---|---|---|
| Live Price | ₹5,586 | ₹33.5 |
| Day Change | -1.68% | -0.53% |
| Volume | 96,858 | 1,104 |
| 52-Week High | ₹5,933.5 | ₹46.34 |
| 52-Week Low | ₹4,738.5 | ₹25.6 |
| Distance from 52W High | -5.86% | -27.71% |
Valuation
| Metric | ALKEM | BIOFILCHEM |
|---|---|---|
| Market Cap | ₹66,765 Cr | ₹54 Cr |
| P/E Ratio | 29.54x | — |
| P/B Ratio | 4.92x | — |
| EPS | ₹192.78 | ₹1.71 |
| Book Value | ₹1,155.47 | ₹13.21 |
| Dividend Yield | 0.35% | 0% |
Growth
| Metric | ALKEM | BIOFILCHEM |
|---|---|---|
| Revenue Growth (TTM YoY) | 14.6% | -9.3% |
| EPS Growth (TTM YoY) | -22.7% | 10.8% |
| Qtr Sales Growth | 14.6% | -9.34% |
| Qtr Profit Growth | 2.04% | 5% |
Profitability & Leverage
| Metric | ALKEM | BIOFILCHEM |
|---|---|---|
| ROE | 18.9% | 13.8% |
| ROCE | 21.2% | 15.8% |
| Net Margin | 15.65% | 9.81% |
| Operating Margin | 20.4% | 2.29% |
| Debt to Equity | 0.15x | 0.14x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | ALKEM | BIOFILCHEM |
|---|---|---|
| Promoter Holding | 49.7%▼ 1.5 pp | 46.79% |
| FII Holding | 10.42%▲ 0.26 pp | 0% |
| DII Holding | 22.63%▲ 1.23 pp | 0.08% |
| Public Holding | 17.25% | 53.13% |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Alkem Laboratories Limited and Biofil Chemicals & Pharmaceuticals Limited.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.